Introductions
Referrals, distributors and the people you met on the show floor. Usually open. Rarely planned.
Usually openFor medical device companies that grew on handshakes
Who needs yourdevice todayand has neverheard your name?
Somewhere there is a value analysis committee, a biomed manager or a lab director with the exact problem you solve. They have not met your rep. They were not at your booth. We build the channel that reaches them, run it beside you until it brings real conversations, and then hand the whole thing to your team.
Where you are now
You built this on people who already trusted you.
Most device companies we sit down with grew the honest way. A surgeon told a colleague. A distributor made an introduction. A good show season carried the year.
That network is real, and we would never ask you to give it up. It is simply not a system. You cannot turn it up when a new product line launches. It goes quiet when a trusted rep moves on. And it rarely reaches the hospital two states over that has the same problem and no idea you exist.
The ways in
There are only a few doors into a buying committee. Most companies keep one open.
What you publish
Articles, video and a site that answers what a clinical or procurement buyer asks. Often started, seldom finished.
Often half builtReaching out first
Researched, one to one outreach to the people who sign off. The door most device makers have never opened.
Where we startPaying to be seen
Sponsored placements and paid search. Useful. Expensive when it is the only door you have.
Sometimes openThe channel you never ran
The door you never opened usually has the most room behind it.
Reaching out first makes a lot of device teams uneasy. It sounds like spam, and most unsolicited outreach a clinician receives is exactly that. So we do it the slow, careful way.
Every message starts with research on one real person: their department, the equipment they live with, the problem their role is answerable for. It is written for them and nobody else. A human reads it before it goes. If they say stop, it stops.
Around that core we build what makes a stranger comfortable saying yes. A site that answers the buyer's questions before they ask. Press and video that show the thinking behind the product. Search work so that when someone asks an AI tool for a shortlist, you are on it.
How it runs
We build it, we run it, then it is yours.
Map
Which buyers, which roles, which doors are open and which sit idle.
Build
The research, the messages, the target accounts and the pages a buyer lands on.
Run
Side by side with your team, measured against a baseline we agree with you before we begin.
Hand over
The playbook, the data, the outreach steps and people trained to run them. We do not move in for good.
Start here, free
Your buyer map.
Before anyone talks about building anything, we take a short, honest look at how buyers find you today. You get a plain read on a few questions.
- Which ways in are you running right now, and which have you never tried?
- Who inside your target hospitals and labs actually signs off?
- Where would a new channel fit first, and what would it need from you?
No deck. No obligation.
It is a short read written for your company, sent to you. If the honest answer is that you do not need us, that is what it will say.
What we believe
Device buyers are careful people. They should be. What they buy ends up beside a patient.
So we write to them the way a thoughtful colleague would. Few words. One clear reason to reply. Nothing that wastes a clinician's time.
- No lists bought by the thousand and hoped over.
- No message goes out that a person has not read.
- No lock in. The engine belongs to you at the end.